- Home
- TTAN vs LNTH Comparison
TTAN vs LNTH Comparison
Compare TTAN & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTAN
- LNTH
- Stock Information
- Founded
- TTAN 2012
- LNTH 1956
- Country
- TTAN United States
- LNTH United States
- Employees
- TTAN N/A
- LNTH N/A
- Industry
- TTAN
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- TTAN
- LNTH Health Care
- Exchange
- TTAN NYSE
- LNTH Nasdaq
- Market Cap
- TTAN 10.2B
- LNTH 7.5B
- IPO Year
- TTAN 2024
- LNTH 2015
- Fundamental
- Price
- TTAN $123.50
- LNTH $75.13
- Analyst Decision
- TTAN Buy
- LNTH Strong Buy
- Analyst Count
- TTAN 14
- LNTH 5
- Target Price
- TTAN $119.77
- LNTH $133.80
- AVG Volume (30 Days)
- TTAN 459.6K
- LNTH 1.5M
- Earning Date
- TTAN 06-05-2025
- LNTH 05-07-2025
- Dividend Yield
- TTAN N/A
- LNTH N/A
- EPS Growth
- TTAN N/A
- LNTH N/A
- EPS
- TTAN N/A
- LNTH 3.53
- Revenue
- TTAN $771,878,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- TTAN $19.04
- LNTH $4.96
- Revenue Next Year
- TTAN $13.40
- LNTH $10.25
- P/E Ratio
- TTAN N/A
- LNTH $21.28
- Revenue Growth
- TTAN 25.64
- LNTH 12.53
- 52 Week Low
- TTAN $79.81
- LNTH $75.00
- 52 Week High
- TTAN $131.33
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- TTAN N/A
- LNTH 27.24
- Support Level
- TTAN N/A
- LNTH $77.01
- Resistance Level
- TTAN N/A
- LNTH $81.50
- Average True Range (ATR)
- TTAN 0.00
- LNTH 3.52
- MACD
- TTAN 0.00
- LNTH -1.61
- Stochastic Oscillator
- TTAN 0.00
- LNTH 0.35
About TTAN SERVICETITAN INC
ServiceTitan Inc is an end-to-end technology platform built for contractors to transform the performance of their businesses. The Company's platform provides business owners, technicians, customer service representatives and other key office staff with technology tools designed to help customers grow revenue, drive operational efficiencies, deliver a superior end-customer experience and monitor key business drivers in real-time. The Company also has subsidiaries in Yerevan, Armenia and British Columbia, Canada that primarily serve as research and development and support centers.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.